Found: 11
Select item for more details and to access through your institution.
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 2, p. 1, doi. 10.1002/prp2.470
- By:
- Publication type:
- Article
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.
- Published in:
- CNS Drugs, 2024, v. 38, n. 5, p. 333, doi. 10.1007/s40263-024-01084-1
- By:
- Publication type:
- Article
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 3, p. 309, doi. 10.1001/jamaneurol.2019.4200
- By:
- Publication type:
- Article
Erratum to: Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.
- Published in:
- Human Molecular Genetics, 2021, v. 30, n. 13, p. 1271, doi. 10.1093/hmg/ddab082
- By:
- Publication type:
- Article
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.
- Published in:
- Human Molecular Genetics, 2020, v. 29, n. 17, p. 2882, doi. 10.1093/hmg/ddaa177
- By:
- Publication type:
- Article
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 3, p. 740, doi. 10.1002/mds.28389
- By:
- Publication type:
- Article
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12296
- By:
- Publication type:
- Article
Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 4, p. 1033, doi. 10.1007/s40120-023-00486-5
- By:
- Publication type:
- Article
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's Disease.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 2, p. 459, doi. 10.1007/s40120-022-00433-w
- By:
- Publication type:
- Article
Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.
- Published in:
- Patient Preference & Adherence, 2015, v. 9, p. 725, doi. 10.2147/PPA.S75459
- By:
- Publication type:
- Article
A New Drug for an Old Condition?
- Published in:
- Headache: The Journal of Head & Face Pain, 2002, v. 42, n. 7, p. 695, doi. 10.1046/j.1526-4610.2002.02164.x
- By:
- Publication type:
- Article